Prosight Management, LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 86 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,814,000
+22.9%
450,000
+210.9%
0.80%
-26.4%
Q2 2018$1,476,000
-23.6%
144,752
-2.6%
1.08%
-10.7%
Q1 2018$1,933,000
-39.5%
148,682
-16.7%
1.21%
-48.4%
Q4 2017$3,194,000178,4532.35%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders